Skip to main content
Log in

Immunvermittelte Epilepsien und Enzephalopathien

Immune-mediated epilepsy and encephalopathy

  • Leitthema
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

Zusammenfassung

Während der letzten 10 Jahre etablierten sich neue Erkenntnisse zur immunvermittelten Genese von Erkrankungen der grauen Substanz des Zentralnervensystems. Diese gehen in ca. 80% der Fälle mit Anfällen einher und imponieren häufig als pharmakoresistente Epilepsien. Wesentlich für die Charakterisierung dieser Erkrankungen war die Entdeckung von Auto-Antikörpern (AK) gegen neuronale Oberflächenantigene (NOA). Immunvermittelte Epilepsien zeigen oft ein unzureichendes Ansprechen auf Antiepileptika. Sie sprechen jedoch in vielen Fällen auf Immuntherapien an. Insofern bieten sich hier Chancen für eine Überwindung von Antiepileptikaresistenz durch immunologische Therapien.

Summary

During the last decade new knowledge on immune-mediated disorders of the grey substance of the central nervous system (CNS) has been generated. These conditions are associated with seizures in approximately 80% of cases and often present as drug-resistant epilepsies. The discovery of autoantibodies against neural surface antigens was essential for the identification of these disorders. Immune-mediated epilepsies often respond poorly to antiepileptic drugs; however, they do respond in many cases to immunological therapy which offers a chance of overcoming resistance to antiepileptic drugs by immunological treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Ances BM, Vitaliani R, Taylor RA et al (2005) Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 128:1764–1777

    Article  PubMed  Google Scholar 

  2. Bien CG, Elger CE (2007) Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life. Epilepsy Behav 10:529–538

    Article  PubMed  Google Scholar 

  3. Bien CG, Rüegg S, Schmutzhard E et al (2012) Immunvermittelte Erkrankungen der grauen ZNS-Substanz sowie Neurosarkoidose. In: Diener HC, Putzki N (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie. Georg Thieme, Stuttgart/New York, S 476–487

  4. Bien CG, Urbach H, Schramm J et al (2007) Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology 69:1236–1244

    Article  PubMed  CAS  Google Scholar 

  5. Bien CG, Vincent A, Barnett MH et al (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 135:1622–1638

    Article  PubMed  Google Scholar 

  6. Boronat A, Gelfand JM, Gresa-Arribas N et al (2012) Encephalitis and antibodies to DPPX, a subunit of Kv4.2 potassium channels. Ann Neurol (in press)

  7. Castillo P, Woodruff B, Caselli R et al (2006) Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 63:197–202

    Article  PubMed  Google Scholar 

  8. Dalmau J, Lancaster E, Martinez-Hernandez E et al (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63–74

    Article  PubMed  CAS  Google Scholar 

  9. Dalmau J, Tuzun E, Wu HY et al (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36

    Article  PubMed  CAS  Google Scholar 

  10. Geschwind MD, Tan KM, Lennon VA et al (2008) Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol 65:1341–1346

    Article  PubMed  Google Scholar 

  11. Graus F, Boronat A, Xifro X et al (2010) The expanding clinical profile of anti-AMPA receptor encephalitis. Neurology 74:857–859

    Article  PubMed  CAS  Google Scholar 

  12. Graus F, Delattre JY, Antoine JC et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psych 75:1135–1140

    Article  CAS  Google Scholar 

  13. Gultekin SH, Rosenfeld MR, Voltz R et al (2000) Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123(Pt 7):1481–1494

    Article  PubMed  Google Scholar 

  14. Holzer FJ, Rossetti AO, Heritier-Barras AC et al (2012) Antibody-mediated status epilepticus: a retrospective multicenter survey. Eur Neurol 68:310–317

    Article  PubMed  CAS  Google Scholar 

  15. Irani SR, Alexander S, Waters P et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133:2734–2748

    Article  PubMed  Google Scholar 

  16. Irani SR, Bera K, Waters P et al (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655–1667

    Article  PubMed  Google Scholar 

  17. Irani SR, Bien CG, Lang B (2011) Autoimmune epilepsies. Curr Opin Neurol 24:146–153

    Article  PubMed  CAS  Google Scholar 

  18. Irani SR, Michell AW, Lang B et al (2011) Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 69:892–900

    Article  PubMed  Google Scholar 

  19. Lai M, Hughes EG, Peng X et al (2009) AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65:424–434

    Article  PubMed  CAS  Google Scholar 

  20. Lancaster E, Lai M, Peng X et al (2010) Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9:67–76

    Article  PubMed  CAS  Google Scholar 

  21. Lancaster E, Martinez-Hernandez E, Dalmau J (2011) Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 77:179–189

    Article  PubMed  CAS  Google Scholar 

  22. Lancaster E, Martinez-Hernandez E, Titulaer MJ et al (2011) Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 77:1698–1701

    Article  PubMed  CAS  Google Scholar 

  23. Liimatainen S, Peltola M, Sabater L et al (2010) Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 51:760–767

    Article  PubMed  Google Scholar 

  24. Malter MP, Helmstaedter C, Urbach H et al (2010) Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67:470–478

    Article  PubMed  Google Scholar 

  25. Mcknight K, Jiang Y, Hart Y et al (2005) Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65:1730–1736

    Article  PubMed  CAS  Google Scholar 

  26. Niehusmann P, Dalmau J, Rudlowski C et al (2009) Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol 66:458–464

    Article  PubMed  Google Scholar 

  27. Novillo-Lopez ME, Rossi JE, Dalmau J et al (2008) Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man. Neurology 70:728–729

    Article  PubMed  Google Scholar 

  28. Schmitt SE, Pargeon K, Frechette ES et al (2012) Extreme delta brush: A unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 79:1094–1100

    Article  PubMed  Google Scholar 

  29. Shavit YB, Graus F, Probst A et al (1999) Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis. Ann Neurol 45:255–258

    Article  PubMed  CAS  Google Scholar 

  30. Stich O, Klages E, Bischler P et al (2012) SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes. Acta Neurol Scand 125:326–331

    Article  PubMed  CAS  Google Scholar 

  31. Vincent A, Bien CG, Irani SR et al (2011) Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 10:759–772

    Article  PubMed  CAS  Google Scholar 

  32. Voltz R, Blaes F, Rauer S et al (2008) Paraneoplastische Syndrome. In: Leitlinien für Diagnostik und Therapie in der Neurologie. Georg Thieme, Stuttgart, S 654 ff

  33. Wieser S, Kelemen A, Barsi P et al (2005) Pilomotor seizures and status in non-paraneoplastic limbic encephalitis. Epileptic Disord 7:205–211

    PubMed  Google Scholar 

  34. Zuliani L, Graus F, Giometto B et al (2012) Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psych 83:638–645

    Article  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist für sich und seinen Koautor auf folgende Beziehungen hin: C.G. Bien und C. Kramme führen im Labor ihrer Klinik Serum- und Liquordiagnostik bezüglich der im Text beschriebenen Antikörper durch. Für diese Diagnostik rechnet ihre Klinik mit auswärtigen Einsendern Gebühren ab. C.G. Bien erhielt Reisekostenunterstützung von folgenden Firmen: Eisai, UCB, Desitin, Grifols; Vortragshonorare von folgenden Firmen: Eisai, UCB, GlaxoSmithKline, Desitin; Honorare für die Mitarbeit in Advisory Boards der folgenden Firmen: UCB, Eisai.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Kramme.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kramme, C., Bien, C. Immunvermittelte Epilepsien und Enzephalopathien. Nervenarzt 84, 442–449 (2013). https://doi.org/10.1007/s00115-012-3605-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-012-3605-7

Schlüsselwörter

Keywords

Navigation